Stockscreener 앱 받기
2.88
6.49%
-0.20
시장 영업 전:
2.95
0.07
+2.43%
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
Icecure Medical Ltd (ICCM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Icecure Medical Ltd (ICCM) Institutional Confidence - TradingKey
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IceCure Medical Kicks Off Post-Marketing ChoICE Study for ProSense Cryoablation in Low-Risk Breast Cancer Treatment at First U.S. Clinical Site - marketscreener.com
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IceCure Medical launches U.S. post-marketing st... - Pluang
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site - PR Newswire
Icecure Medical Ltd (ICCM) Cash Flow - TradingKey
IceCure Medical Ltd. Revenue Breakdown – NASDAQ:ICCM - TradingView
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IceCure Medical (ICCM) Slumps 4.64% as Support Levels LoomPSAR Stop - dars.gov.et
ICCM|Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
Icecure Medical Ltd|Price:3.080|Chg%:-0.150 - TradingKey
TradingKey - TradingKey
Why Has IceCure Medical's Stock Price Collapsed - Kavout | AI
IceCure Medical Faces Sharp Decline: ICCM Drops 9.6% as Support Levels Are TestedLarge Cap Trends - dars.gov.et
Price to sales forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Meir Peleg Net Worth (2026) - GuruFocus
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation - Sahm
ICCM: First FDA-cleared minimally invasive cryoablation device for breast cancer, driving global growth - TradingView
IceCure Medical (ICCM) Expands U.S. Team to Meet Growing Demand for ProSense® System - GuruFocus
IceCure Medical (ICCM) Expands Sales and Marketing Teams Nationw - GuruFocus
Enterprise value to revenue forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer - AOL.com
IceCure Medical Ltd. emphasized that following FDA approval for breast cancer treatment, the commercial application of its Prosense™ cryoablation system is continuously expanding in Brazil. - Bitget
IceCure Medical (ICCM) Expands Presence in Brazil with ProSense System - GuruFocus
IceCure Medical Highlights Expanding Commercial Adoption Of ProSense Cryoablation In Brazil Following FDA Clearance For Breast Cancer - marketscreener.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer - Barchart.com
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Medical (ICCM) Gains Ground: Support Holds, Resistance AheadMAMA Signal - DonanımHaber
Enterprise value to EBITDA forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Price to earnings forward of IceCure Medical Ltd. – NASDAQ:ICCM - TradingView
Warrant repricing at IceCure Medical (NASDAQ: ICCM) heads to shareholder vote - Stock Titan
IceCure Medical Ltd. Actuals & Estimates (NASDAQ:ICCM) - TradingView
IceCure regains compliance with NASDAQ - MSN
IceCure regains compliance with Nasdaq MBP requirement - Medical Buyer
What's going on with IceCure Medical stock on Friday? - MSN
IceCure Medical Faces Certified Class Action Over 2021 Private Placement, Plans Court Challenge - The Globe and Mail
Why Is IceCure (NASDAQ:ICCM) Catching Small-Cap Attention? - Kalkine Media
IceCure Medical Ltd. Actuals & Estimates (BOATS:ICCM) - TradingView
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC FilingForm 6-K - Stock Titan
What's Going On With IceCure Medical Stock On Friday? - Benzinga
IceCure Medical Regains Nasdaq Compliance on Minimum Bid Price - The Globe and Mail
Icecure Medical(ICCM) Stock Options Chain | Quotes & News - Moomoo
IceCure Medical Files to Register Sale of 5.5 Million Shares by Armistice - marketscreener.com
ICCM: Selling Stockholders Plan to Offer 5.5 Million Shares - GuruFocus
IceCure Medical (ICCM) registers 5.5M shares tied to June 2026 warrants - Stock Titan
ICCM Forecast — Price Target — Prediction for 2027 - TradingView
IceCure Medical Ltd (ICCM) stock price, news, quote and history - Yahoo Finance Australia
IceCure Medical (Nasdaq: ICCM) back in compliance with bid price rule - Stock Titan
IceCure clears Nasdaq bid-price warning after 10-day run - Stock Titan
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
$Icecure Medical (ICCM.US)$ - Moomoo
$Icecure Medical (ICCM.US)$ enough too 🫰🏽 - Moomoo
0.79%
4.39%
자본화:
|
볼륨(24시간):